A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

NCT06095128 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Vedolizumab
DRUG: Tofacitinib

Sponsor

Takeda